Content about Berlin

March 8, 2013
Mhealth market to see strong revenue growth through 2017, study finds

The global market for mobile health app services is expected to reach $26 billion by 2017 as smartphone applications allow the mhealth industry to successfully monetize its services, according to a new report.

BERLIN — The global market for mobile health app services is expected to reach $26 billion by 2017 as smartphone applications allow the mhealth industry to successfully monetize its services, according to a new report.

Global Mobile Health Market Report 2013-2017, announced Friday by Berlin-based mobile market research firm Research2guidance, found that top mhealth publishers manage to generate more than 3 million free and 300,000 paid downloads in the United States on the Apple iOS platform.

October 3, 2012
Study: Lilly, BI drug lowers blood sugar in elderly Type 2 diabetes, adult diabetic nephropathy patients

A drug marketed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly reduced blood sugar in elderly patients with Type 2 diabetes and in adults with diabetic nephropathy, according to results of three studies presented at a diabetes meeting in Berlin.

INDIANAPOLIS — A drug marketed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly reduced blood sugar in elderly patients with Type 2 diabetes and in adults with diabetic nephropathy, according to results of three studies presented at a diabetes meeting in Berlin.

October 11, 2011
ReportersNotebook — General Merchandise, 10/10/11

Energizer’s power-on-the-go products made their debut at the IFA Consumer Electronics Global Trade Show in Berlin last month.


SUPPLIER NEWS — Energizer’s power-on-the-go products made their debut at the IFA Consumer Electronics Global Trade Show in Berlin last month.


The lineup includes the portable charger line’s new design; the SP1001 solar charger; the AP750, which adds extra talk time for almost any micro-USB smartphone; the AP1201 for the iPhone 4, a silicone rubber case with built-in rechargeable battery; and the XP2000K and XP1000K travel kits, which offer all-in-one portable power for the home, car and all points in between.


September 28, 2011
World Retail Congress recognizes Walgreens as Retail Advertising Campaign of the Year

Walgreens was awarded the Retail Advertising Campaign of the Year at the Oracle World Retail Awards at the German Historical Museum during the annual World Retail Congress held Tuesday.

BERLIN — Walgreens was awarded the Retail Advertising Campaign of the Year at the Oracle World Retail Awards here at the German Historical Museum during the annual World Retail Congress held Tuesday.

The Retail Advertising Campaign of the Year celebrates outstanding advertising campaigns undertaken by a retailer to build the brand. Walgreens was selected over the competition and was awarded the prize due to its “Arm Yourself for the Ones You Love” campaign by Arc Worldwide.

September 6, 2011
Energizer presents latest innovations at trade show

Energizer's latest portable power solutions are making their debut at the IFA Consumer Electronics Global Trade Show in Berlin this week.

BERLIN — Energizer's latest portable power solutions are making their debut at the IFA Consumer Electronics Global Trade Show in Berlin this week.

The brand's power-on-the-go lineup includes:

July 14, 2011
Bayer HealthCare study suggests acne treatment may help sufferers with postinflammatory hyperpigmentation

A new study conducted by Bayer HealthCare suggests that an investigational treatment for acne may be suitable for patients with dark complexions whose acne includes a condition that causes irregular discoloration of the skin known as postinflammatory hyperpigmentation, or PIH.

BERLIN — A new study conducted by Bayer HealthCare suggests that an investigational treatment for acne may be suitable for patients with dark complexions whose acne includes a condition that causes irregular discoloration of the skin known as postinflammatory hyperpigmentation, or PIH.

April 8, 2011
Regeneron, Bayer commence phase-3 trial for diabetic macular edema treatment

Regeneron and Bayer HealthCare have initiated 1-of-2 late-stage clinical trials of their aflibercept ophthalmic solution in the treatment of a complication caused by diabetic retinopathy.

TARRYTOWN, N.Y. and BERLIN — Regeneron and Bayer HealthCare have initiated 1-of-2 late-stage clinical trials of their aflibercept ophthalmic solution in the treatment of a complication caused by diabetic retinopathy.

The drug makers said that it would evaluate the efficacy of VEGF Trap-Eye (aflibercept ophthalmic solution) in the treatment of diabetic macular edema, a prevalent cause of vision loss among diabetes patients, after promising results from its previous clinical trial.

December 2, 2010
Study: Lansinoh HPA Lanolin may reduce nipple pain among breast-feeding mothers

A new study released Thursday determined that directed use of Lansinoh HPA Lanolin results in a marked reduction of nipple pain associated with breast-feeding and in significantly higher healing rates of nipple trauma compared with application of expressed breast milk. The researchers concluded that “the current recommendation for any topical treatment of sore nipples during breast-feeding should be revised in favor of HPA lanolin.”

ALEXANDRIA, Va. — A new study released Thursday determined that directed use of Lansinoh HPA Lanolin results in a marked reduction of nipple pain associated with breast-feeding and in significantly higher healing rates of nipple trauma compared with application of expressed breast milk. The researchers concluded that “the current recommendation for any topical treatment of sore nipples during breast-feeding should be revised in favor of HPA lanolin.”